truss20: "DFU P1" Dec 23 / "Renal P1" Dec 24 and "GvHD P2" 30 June 25/ "OA P3" Dec 25.
truss20/others: The trials with significant data that lead to substantial share-price increases are NORMALLY "only" the ones in Phase 2 or (of course) in Phase 3.... Therefore, it might be a LONG WAIT here for seeing a really substantial shifting in the share-price?? So be it. IF CYP has really that much "promise" why would a bigger pharma company not proceed with a take-over now when the total valuation of CYP is so depressed? Comments most welcome.
wasa
CYP Price at posting:
31.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)